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Abstract 
The analysis of tear constituents at point-of-care settings has a potential for early diagnosis of 
ocular disorders such as dry eye disease, low-cost screening and surveillance of at-risk subjects. 
However, current minimally-invasive rapid tear analysis systems for point-of-care settings have 
been limited to assessment of osmolarity or inflammatory markers and cannot differentiate 
between dry eye subclassifications. Here, we demonstrate a portable microfluidic system that 
allows for quantitative analysis of electrolytes in the tear fluid that is well suited at point-of-care 
settings. The microfluidic system consists of a capillary tube for sample collection, a chamber for 
sample dilution, and a paper-based microfluidic device for electrolyte analysis. The sensing 
regions are functionalized with fluorescent crown ethers, o-acetanisidide, and 
seminaphtorhodafluor that are sensitive to mono- and divalent electrolytes, and their 
fluorescence outputs are measured with a compact handheld spectrometer and a smartphone 
readout device. The measured sensitivity values of Na+, K+, Ca2+ ions and pH in artificial tear 
fluid were matched with the known ion concentrations within the physiological range. The 
microfluidic system was tested with samples with different ionic concentrations, demonstrating 
the feasibility for the detection of early-stage dry eye, differential diagnosis of dry eye sub-types, 
and their severity staging. 
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The tear fluid offers a broad potential for sensing the physiological status and for the diagnosis of 
ocular diseases and metabolic dysfunction.1-3 The tear film maintains a smooth optical refracting 
surface and minimizes and prevents the risk of the eye infection through its flushing action and 
antimicrobial constituents.4, 5 It comprises an outer lipid layer, an aqueous layer, and an inner 
mucin layer.6, 7 The aqueous layer (~4-50 µm) consists of proteins and electrolytes.8 Inadequate 
tear production or rapid tear film evaporation results in dry eye syndrome, which is caused by 
Meibomian Gland Dysfunction (MGD, blockage of oil glands) and/or Lacrimal Gland 
Dysfunction (LGD, aqueous tear deficiency).9, 10 Differentiating MGD and LGD and their 
severity stages are important because they require different treatment approaches (e.g., eye drops 
(aqueous/lipid), unclogging the glands, heat treatment, punctal plugs).11, 12 Without early 
diagnosis and accurate treatment of ocular disease, dry eye results in impaired vision, discomfort 
and eventually blindness.13 Furthermore, the diagnosis of early-stage dry eye is required before 
and after refractive surgeries (e.g. Laser-Assisted In Situ Keratomileusis) that severs corneal 
nerves, often leading to post-operation dry eye.14-16 Additionally, dry eye is a reason for contact 
lens discontinuations. Early diagnosis can assist eye care practitioners to choose an appropriate 
lens type.17, 18 However, quantitative diagnostics are required not only for the early detection of 
dry eye, but also differential diagnosis of its subtypes and severity stages. 
The development of diagnostic devices for dry eye syndrome dates back to the 1900s. Otto 
Schirmer developed a semi-quantitative test for measuring tear volume on the ocular surface.19 
Schirmer’s test can be used without anesthetics for the measurement of reflex tear secretion in 
response to conjunctival stimulation.19 The pH-sensitive phenol red thread test is another semi-
quantitative measurement device for detecting dry eye syndrome.20 The development of rapid 
diagnostic devices for analyzing tear fluid has been limited over the last two decades. An 
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important development was a clinically-used benchtop osmometer (TearLab, San Diego, CA, 
USA).21 This device measures the conductivity in tear fluid (50 µL) and correlates the 
measurement with an osmolarity value, providing a quantitative readout to diagnose dry eye 
syndrome. However, clinical interpretation of osmolarity readings for the diagnosis of dry eye 
have been questioned.22 Lateral-flow assays have been also utilized for detecting analytes in tear 
fluid. In 2013, the Food and Drug Administration (FDA) approved a lateral-flow diagnostic test 
(InflammaDry, Rapid Pathogen Screening Inc., Sarasota, FL, USA) that measures the 
concentration of matrix metalloproteinase-9 (MMP-9) for the diagnosis of dry eye.23, 24 The 
concentration of MMP-9 has been shown to be elevated in the tears of patients with dry eye 
disease.25 However, this assay requires multiple sample processing steps and gives a binary 
response limiting its value in determining severity. Additionally, Tearscan (Advanced Tear 
Diagnostics, Birmingham, AL, USA) is a lateral-flow assay that has a dynamic range from 0.25-
2.50 mg mL-1 of lactoferrin which is an indicator of aqueous tear production.26 This test is 
potentially useful when combined with IgE (allergen testing) measurement.27 Recently, an 
alkaline microfluidic homogeneous immunoassay was demonstrated for the determination of the 
low-volume (< 1 µL of tear) lactoferrin at clinically relevant concentrations.28 Another recent 
study utilized an inkjet-printed device for the measurement of lactoferrin concentration in tear 
fluid.29 
The measurement of tear electrolytes can be used to identify dry eye at different severity 
stages and differentiate its sub-types such as MGD and LGD. The Na+ ion concentration in the 
tears of healthy individuals ranges between 120-165 mmol L-1.30 However, in dry eye syndrome 
caused by MGD or LGD, Na+ ion concentration in human tear increase was reported to be 
significant, which can be detected by a sensor sensitivity of ~3.0 mmol L-1.31 Additionally, 
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divalent metal ion concentration was found to be different in MGD and LGD. As compared to 
MGD, human tear Ca2+ ion concentration in LGD significantly increases and could potentially 
detected by a sensor sensitivity of 20-40 µmol L-1.31 Hence, the accurate measurement of tear 
electrolytes can provide quantitative data for dry-eye diagnosis. Therefore, the development of a 
minimally-invasive diagnostic system for the quantitative analysis of tear electrolytes is highly 
desirable for the detection of dry eye in different severity stages and classification of its subtypes. 
Such a quantitative device can be used to screen for at-risk dry eye patients, enable the early 
detection of dry eye, and improved management approaches. 
This paper reports on the development of a microfluidic system for application in the 
quantitative analysis of electrolytes in tear fluid (Fig. 1). Upon introducing a low-volume sample 
(e.g., tear fluid), the microfluidic device distributed the sample into sensing regions that were 
functionalized with fluorescent sensing agents. The microfluidic device was placed in a portable 
readout device that consisted of various LED illumination wavelengths for fluorescence 
excitation. A smartphone application (app.) was utilized to capture the fluorescence assay images 
which were digitally processed by ImageJ (software) to obtain concentration values for the 
quantitative analysis of electrolytes in artificial tear fluid.  
 
Figure 1. Principle of operation of the microfluidic system for the quantitative analysis of 
electrolytes in tear film. 
 6 
EXPERIMENTAL SECTION 
Materials. All chemicals were of analytical grade and used without further purification. 
Tetra(tetramethylammonium) salt (tetrakis(N,N,N-trimethylmethanaminium) 3,3'-{1,4,10-trioxa-
7,13-diazacyclopentadecane-7,13-diylbis [(2,5-dimethoxy-4,1-phenylene) carbamoyl]}bis[6-
(2,7-dichloro-6-oxido-3-oxo-3H-xanthen-9-yl) benzoate]) (fluorescent diaza-15-crown-5, HPLC 
purity≥90%, λex/λem: 507/532 nm); 1,3-benzenedicarboxylic acid, 4-[6-[16-[2-(2,4-
dicarboxyphenyl)-5-methoxy-1-benzofuran-6-yl]-1,4,10,13-tetraoxa-7,16-diazacyclooctadec-7-
yl]-5-methoxy-1-benzo (fluorescent diaza-18-crown-6, HPLC purity≥90%, λex/λem: 346/500 nm); 
N-(2-methoxyphenyl)iminodiacetate chelator (o-acetanisidide, λex/λem: 495/515 nm), and 
benzenedicarboxylic acid 2(or 4)-[10-(dimethylamino)-3-oxo-3H-benzo[c]xanthene-7-yl] 
(seminaphtorhodafluor, λex/λem: 530/640 nm) were purchased from Thermo Fisher Scientific. 
Whatman qualitative filter paper (grade 1, grade 41), tris base (99.9%), tris hydrochloride (tris 
HCl, 99%), sodium chloride (NaCl) (99%), potassium chloride (KCl) (99.0%), magnesium 
chloride (MgCl2) (98%), calcium chloride dihydrate (CaCl2·2H2O) (99%), iron(III) chloride 
hexahydrate (FeCl3·6H2O) (97%), copper(II) chloride dihydrate (CuCl2·2H2O) (99.0%), 
nickel(II) sulfate hexahydrate (NiSO4·6H2O) (99%), ammonium chloride (NH4Cl) (99.0%), citric 
acid (99.0%), L-ascorbic acid (99.0%), albumin (bovine serum) (96%), lysozyme (chicken egg 
white) (90%), D-(+)-glucose (99.5%), dimethyl sulfoxide (DMSO)(anhydrous, 99.9%), 
Rhodamine B (95%) were purchased from Sigma-Aldrich. Polydimethylsiloxane (PDMS) 
elastomer (SYLGARD® 184 Silicone elastomer kit) was purchased from Dow Corning. An 
opaque black polymethyl methacrylate (PMMA) sheet (thickness: ~3 mm) was purchased from 
McMaster-Carr. 
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Equipment. A CO2 laser (VLS2.30) operating at a wavelength of 10.64 µm at 30 W was 
purchased from Universal Laser Systems. An optical microscope (IX51) with phase contrast and 
fluorescence imaging was purchased from Olympus. A charge-coupled device (CCD) (2 MP) 
color digital microscope camera was purchased from Spot RT3. A fluorescence plate reader 
(Synergy 2 Multi-Mode Reader) was purchased from BioTek. An electrochemical pH sensor was 
purchased from Mettler Toledo. Capillary tubes (5 µL) were purchased from CM Scientific. A 
digital single-lens reflex camera (D90, 12.3 MP) and a lens (AF-S DX 18-105 mm f/3.5-5.6G 
ED VR) were purchased from Nikon. A portable UV light (λ=354 nm) was purchased from 
Thermo Scientific. Longpass colored glass filters were purchased from Thorlabs (420, 495, 515, 
590 nm). SolidWorks (x64), CorelDRAW (X7), and Image J (1.50h) were used for design and 
image processing. Images were captured using an iPhone 6S using a smartphone app. (Shoot, 
ProCam). The spectrophotometer was purchased from Thorlabs (CCS100). 
Laser cutting of paper-based microfluidic devices. A CO2 laser (λ=10.64 µm, 30 W) was 
used to pattern paper. Images were designed in CorelDRAW and defined as lines. The lengths of 
the paper-based microfluidic devices were varied from 10 to 40 mm with channel widths ranging 
from 2.0 to 5.0 mm. The fluence of laser beam was varied from 0 to 264 mJ mm-2 at beam 
speeds ranging from 30.0 to 65.5 mm s-1. The platform exhaust operated at 150 cfm and 6.0 mm 
in static pressure (255 m3 h-1, 1.5 kPa). 
Flow rate measurements. The paper-based microfluidic devices were fixed upright on a 
leveled surface. Sample solutions ranging from 10-20 µL were introduced from the inlet and 
images were taken with a digital single-lens reflex camera (12.3 MP) using a lens (AF-S DX 18-
105 mm f/3.5-5.6G ED VR) operating at ISO1600, 1/1500 speed, and F3.5. 
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Preparation of ion solutions, viscous samples, and artificial tear fluid. Two stock 
solutions containing tris base and tris HCl were mixed to obtain pH values from 4.5 to 9.0 with a 
constant ionic strength (150.0 mmol L-1) in deionized water (DI) (18.2 MΩ cm, Millipore) while 
the solution was monitored with an electrochemical pH sensor. NaCl, KCl, MgCl2, CaCl2·2H2O, 
FeCl3·6H2O, CuCl2·2H2O and NiSO4·6H2O were used to obtain ion concentrations ranging from 
25.0 to 200.0 mmol L-1. D-(+)-glucose solutions (0.55-2.78 mol L-1) in DI water were prepared to 
obtain viscosity values ranging from 1.0 to 10.0 mPa s. Artificial tear fluid contained NaCl (125 
mmol L-1), KCl (20 mmol L-1), CaCl2 (1 mmol L
-1), MgCl2 (0.5 mmol L
-1), urea (5 mmol L-1), 
NH4Cl (3 mmol L
-1), citric acid (31 μmol L-1), L-ascorbic acid (8 μmol L-1), albumin (3.94 g L-1), 
lysozyme (1.7 g L-1) and the pH value was adjusted to 7.4 using tris HCl (150 mmol L-1) and tris 
base (150 mmol L-1).32 
Preparation of fluorescent sensors. A stock solution containing fluorescent diaza-15-crown-5 
(MW: 1667.57 g mol-1, λex/λem: 507/532 nm), fluorescent diaza-18-crown-6 (MW: 950.99 g mol-
1, λex/λem: 346/500 nm), fluorescent o-acetanisidide (MW: 599.67 g mol-1, λex/λem: 495/515 nm), 
and seminaphtorhodafluor (MW: 453.45 g mol-1, λex/λem: 530/640 nm) were prepared to obtain 
concentration values ranging from 5.0 to 100.0 µmol L-1 in DMSO (the solution to prevent from 
hydrolysis of the fluorescent probe). The stock solutions were kept in dark and dry conditions at 
-20 °C. 
Readouts of fluorescence measurements. A microplate reader was used to measure the 
fluorescence intensities of the probes in aqueous solution and on paper (Fig. 3-5). Metal ion 
solutions (25.0 to 200.0 mmol L-1) in tris buffer (pH 4.5-9.0, 150.0 mmol L-1) were mixed (1:1, 
v/v) with fluorescent diaza-15-crown-5 (λex/λem: 485/528 nm), diaza-18-crown-6 (λex/λem: 
360/460 nm), o-acetanisidide (λex/λem: 485/528 nm), and seminaphtorhodafluor (λex/λem: 530/590 
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nm) in DMSO (5.0 to 100.0 µmol L-1) and dispensed in 96-well plates (black wall). The 
calibration of the assay was carried out with tris buffer (pH 7.4, 150.0 mmol L-1) mixed (1:1, v/v) 
with the probes in DMSO (5.0 to 100.0 µmol L-1). For paper analysis, the laser-cut round G1 
paper (Ø=6.5 mm) was placed at the bottom of the microwells in 96-well plates. Subsequently, 2 
μL fluorescent probe was dropped onto the paper matrix and dried in the air at 24oC, followed by 
adding 2 μL ion solution. 
Fabrication of the sample collection device. The sample collection device contained a 
capillary tube (5 µL) inserted to an Eppendorf tube (0.5 mL) using PDMS sealing. This part was 
integrated with a paper-based microfluidic device at the other end of the Eppendorf tube. 
Sample preparation. Each fluorescent sensor (diaza-15-crown-5, diaza-18-crown-6, o-
acetanisidide and seminaphtorhodafluor) (2 μL) was added to the top of each branch of the 
paper-based microfluidic device and dried at 24 °C. The paper-based microfluidic device was 
connected to the sampling device, which was utilized to collect artificial tear fluid by capillary 
force and dilute the sample. The diluted artificial tear fluid diffused through the main channel of 
the paper-based microfluidic device to four branches to interact with fluorescent probes in the 
sensing regions. 
Readout system and image analysis. The paper-based microfluidic device with samples 
was placed in a portable readout device for imaging. The readout system consisted of eight 
PMMA pads (5×5×5 cm3). The top part was ablated using a laser beam to form a groove, where 
a smartphone could be placed. The interlayer consisted of a bottom section to fix four LEDs 
(λem= 508, 366, 460, and 515 nm), a middle glass layer to separate sample and LEDs, and a top 
layer to fix the sample. A plano-convex lens (f: 5.0 cm) was used to change the focus on the 
smartphone camera. A 3.6 V battery powered the LEDs. Fluorescence images were captured 
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using a smartphone app. (Shoot, exposure time: 1/4000s, ISO 400) and analyzed by ImageJ 
(Software) (Fig. 6c).33 
Evaporation test. G1 paper was cut into 2 mm-wide strips with different lengths (4 mm, 8 
mm, 16 mm and 32 mm). The fluorescent probe (50 μmol L-1, 2 μL) was dropped onto the 
sensing region of the strip and dried at 24oC. The sample solution (Na+ ion solution, 100 mmo L-
1; K+ ion solution, 50 mmol L-1, Ca2+ ion solution, 1 mmol L-1; Tris buffer, pH=7.4) was wicking 
from the other end of the strip to the sensing region (4, 8, 16, and 32 μL). The fluorescent images 
were captured using a Smartphone app. and analyzed by ImageJ. 
Batch-to-batch experiment. Artificial tear fluid containing Na+ ions varied from 100- 200 
mmol L-1, K+ ions varied from 20-60 mmol L-1, Ca2+ varied from 0.7- 1.0 mmol L-1, and pH 
varied from 7.0-9.0 were prepared respectively. The electrolyte sensing measurement was carried 
out using individual custom-made readout devices. The data analysis was processed using a 
smartphone app. and ImageJ.  
Dilution test. Different volumes of dilution solution (5, 15, 35, 75, 155, and 315 μL) were 
added to the chamber of sample collection device, respectively. 5 μL of artificial tear fluid was 
aspirated into the chamber by using the capillary tube of the sample collection device. The 
electrolyte sensing measurement was carried out using individual custom-made readout devices. 
The data analysis was processed using a smartphone app. and ImageJ.  
 
RESULTS AND DISCUSSION 
Laser ablation was chosen to pattern the microfluidic channels in paper due to its high speed and 
accuracy. Filter paper (Whatman Grade 1, G1) was patterned by a CO2 laser (10.64 µm, 30 W) 
having a beam spot size of ~100 µm. This grade is a widely used filter type for routine chemistry 
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applications. As compared to the other filter paper types such as Grade 41, G1 shows rapid 
filtration time (water flow rate: 57 ml min-1) and low autofluorescence (~30%) (Fig. S1). The 
radiant fluence and beam speed of the CO2 laser were optimized at 240 mJ mm
-2 and 30 mm s-1, 
respectively (Fig. S2). 
To design a paper-based microfluidic device that can operate with tear fluid samples (< 10 µL) 
within a 3-min wicking time (to allow point-of-care application), the geometry of the paper-
based microfluidic device was optimized. Upon introducing DI water from their inlets at a 
constant width (2 mm), the fluid front in G1 strips reached 2 cm within 25 s (Fig. S3). As DI 
water (20 µL) was introduced to G1 strips with different widths at a constant length (3.5 cm), the 
wicking distances of strips with widths from 2-5 mm were similar (Fig. 2a). Figure S4 illustrates 
photographs of the G1 strips with varying channel widths. The G1 strips with 2 mm in width was 
chosen for assay optimization as it operated at low volume and it was easy to handle. The flow 
characteristics of fluid were fit using a modified Navier-Stokes equation (Eq. 1). 
   t =
ηL2
κΔP
                                                                                                   (Eq.1)  
where t is the time for the sample to flow to a certain distance, η is the viscosity of fluid, L is the 
wicking distance, κ is the permeability of fluid, and ΔP is applied pressure difference.34 
The viscosity of human tear fluid ranges from 1 to 10 mPa·s.35 The G1 matrix should have 
fast wicking time for application in rapid diagnostics. The viscosities of the solutions (10 μL) 
introduced to the G1 strips were varied from 1.0 to 10.0 mPa s. While a wicking time of 1 min 
saturated the fluid front at 1.0 mPa s, fluids with 10.0 mPa s required 3 min for fluid front 
saturation (Fig. 2b). The optimized G1 strip had fast sample wicking times at viscosities as high 
as 10.0 mPa·s.  
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Figure 2. Fluid dynamics characterization of G1 paper-based microfluidic devices. (a) Wicking 
distances of G1 strips as the width was varied from 2.0 to 5.0 mm. (b) The effect of increase in 
fluid viscosity from 1.0 to 10.0 mPa·s on wicking distance in G1 strips (20 mm in length and 2 
mm in width). Fluid viscosities were varied by changing concentration of glucose (10 μL) from 
0.5 to 3.0 mol L-1. (c) Wicking distances as the number of branches was increased from 1 to 4 
within 60 s. Sample volume was 10 μL. (d) Photographs of paper-based microfluidic devices 
with different numbers of channels (1 to 4). Scale bar: 4 mm. (e) Bright-field microscopic image 
of G1 matrix. Scale bar: 50 μm. (f) Photographs of a four-channel paper-based microfluidic 
device, where Rhodamine B solution (10 mmol L-1) was used to show fluid diffusion as a 
function of time. Scale bar: 4 mm. Error bars represent standard deviation (n=3). 
 
Figure S5 illustrates the photographs of G1 microfluidic strips wicking fluids with different 
viscosities (1.0-10.0 mPa·s). The effect of having branched channels on the movement of the 
fluid front was also tested. As the number of branches was increased from 1 to 4 at a constant 
main strip width of 2 mm, wicking distances among these strips were comparable within 20 s 
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while and decreased by 14% with increasing number of branches within 20 to 60 s (Fig. 2c). 
Figure 2d shows the fabricated paper-based microfluidic devices with different number of 
branches. The G1 matrix consists of cellulose with porous structure having a particle retention 
value of 11 µm (Fig. 2e). Figure 2f shows the photographs of the paper-based microfluidic 
devices as the Rhodamine B solution (10 mmol L-1) was wicked from the main channel. The 
optimized paper-based microfluidic device with four branches allowed the transport of fluid 
samples (< 20 µL) from the inlet to the branches under 1.5 min (Fig. S6). 
Assay conditions of fluorescent chelating agents were optimized for functionalizing paper-
based microfluidic devices. Crown ethers are cyclic chelating agents that are specific to 
monovalent metal ions.36 They form stable complexes with cations by ion-dipole interaction 
between a metal ion and negatively charged oxygen atoms in the polyether ring.37 The changes in 
fluorescence intensity on monovalent metal ion binding are caused by conformational or 
electronic changes that possibly occur in electron transfer between ground state and excited state 
of fluorophore due to electron density changes at the ion binding site.38, 39 Fluorescent diaza-15-
crown-5 (cavity size: 0.17-0.22 nm) and diaza-18-crown-6 (cavity size: 0.26-0.32 nm) for 
selectively sensing Na+ and K+ ions, respectively were utilized (Fig. 3a). In the presence of 
diaza-15-crown-5 (25 µmol L-1) in buffer solution (tris, pH 7.4, 150 mmol L-1) at 25 °C, Na+ ions 
(100.0 mmol L-1) had the highest fluorescence intensity due to the cavity specific 1:1 chelation 
(Fig. 3b). The diaza-15-crown-5 response to Na+ ions was 3.5 fold higher as compared to K+ 
ions. In the presence of diaza-18-crown-6, K+ ions showed the highest selectivity (Fig. 3b). The 
diaza-18-crown-6 selectivity to K+ ions was 1.8 fold higher than Na+ ions. The interference due 
to Na+ ions could be due to 2:1 complexation with diaza-18-crown-6 cavity. To analyze ion 
binding affinity, the dissociation constants (Kd, the ion concentration at which 50% of crown 
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ethers (receptors) are chelated by ions) of Na+ and K+ binding to fluorescent crown ether 
derivatives were determined as 14 mmol L-1 and 5.8 mmol L-1 respectively in tris buffer solution 
(150 mmol L-1, pH=7.4): 
[Ion+]free = 𝐾d[
F−Fmin
Fmax−F
]                                                                                                   (Eq. 2) 
where [Ion+]free is the free ion concentration of the solution, F is the fluorescence intensity at a 
given ion concentration, Fmin is the fluorescence intensity at the ion-free concentration, and Fmax 
is the fluorescence intensity at the ion-saturated concentration. Kd for Na
+ and K+ ions match the 
previously reported values for Na+ ions (5-20 mmol L-1) and K+ ions (5.1 mmol L-1) of in the 
physiological range (pH 6-8).38 
Increasing pH from 7.0 to 8.0 enhanced the fluorescence intensities 0.2% and 3.0% for diaza-
15-crown-5 and diaza-18-crown-6 respectively, showing stability within the physiological pH 
range (~7.4) of tear fluid (Fig. 3c). The fluorescence intensities of both diaza-15-crown-5 and 
diaza-18-crown-6 depended on their concentrations. As their concentrations increased from 3 
µmol L-1 to 50 µmol L-1 in buffer solutions (tris-buffer, pH 7.4, 150 mmol L-1), their 
fluorescence intensities increased 10 and 13 fold, respectively (Fig. S7). When the temperature 
increased from 25 to 40 °C, the fluorescence intensity of diaza-15-crown-5 decreased ~20% (Fig. 
S8). However, the diaza-18-crown-6 fluorescence intensity variation was ~2% between 25 to 35 
°C, decreasing ~7% at 40 °C (Fig. S8). 
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Figure 3. Na+ and K+ ion measurements using fluorescent crown ether derivatives in buffer 
solutions (tris, pH 7.4, 150.0 mmol L-1). (a) Chelation mecha nisms of fluorescent (i) diaza-15-
crown-5 and (ii) diaza-18-crown-6 with monovalent metal ions. (b) Selectivities of diaza-15-
crown-5 and diaza-18-crown-6 (25 µmol L-1) for mono/divalent ions (100.0 mmol L-1) in 
aqueous solutions. (c) The effect of pH on fluorescence readouts at constant Na+ and K+ ions 
(100.0 mmol L-1) and diaza-15-crown-5 and diaza-18-crown-6 (25 µmol L-1) concentrations in 
aqueous solutions. Quantifications of 16-fold diluted (d) Na+ and (e) K+ ions on G1 matrix at a 
constant probe concentration (25 µmol L-1). Insets show the quantifications of non-diluted Na+ 
and K+ ions on G1 matrix. Error bars represent the standard deviation (n=3). Shadows in Fig. 3c-
e show the physiological pH, Na+ ion and K+ ion range.  
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The concentration of Na+ ions in tear fluid of healthy individuals is 120-165 mmol L-1.30 In 
dry eye syndrome caused by MGD or LGD, tear Na+ ion concentration increases by 2.2% and 
6.8%, respectively.31 This requires a sensor sensitivity of ~3.0 mmol L-1 and ~9.0 mmol L-1. The 
presence of both MGD and LGD increases the Na+ ion concentration by 8.9%, requiring a 
sensitivity of ~12.0 mmol L-1.40 G1 paper (32 mm2) was used as a reaction matrix to quantify 
concentrations of electrolytes. Probe solutions (2 µL, 25 µmol L-1 in DMSO) were immobilized 
on the G1 matrix, followed by adding ion solutions (2 µL, tris-buffer, pH 7.4, 150 mmol L-1) to 
the G1 matrix. The fluorescent probes dissolved DMSO (2 µL) were inoculated on G1 paper, 
which was dried at 24oC for 2 min (Fig. S9). As the concentration of Na+ ions in the presence of 
diaza-15-crown-5 on G1 matrix increased from ion-free buffer solution (tris, pH 7.4, 150 mmol 
L-1) to 200 mmol L-1, the fluorescence intensity of the probe increased by 1.9 fold (Fig. 3d inset). 
To detect Na+ ions within the physiological concentration range of tear fluid (100-200 mmol L-
1), the samples were diluted 16 fold (4 serial two-fold dilutions). After dilution, the fluorescence 
intensity of probes within the physiological Na+ ion range (100-200 mmol L-1) increased 12.2% 
(Fig. 3d, Fig. S10a). The sensitivity of the diluted Na+ ion sensor on G1 matrix was calculated to 
be 2.0 mmol L-1, which met the requirement for the diagnosis of dry eye. Sensitivity values from 
three independent measurements were calculated by averaging the standard error of the intensity 
ratio (I/I0) on the slope within the physiological disease detection range, followed by reading the 
corresponding electrolyte concentration values (mmol L-1) in the x-axis (Supporting Information 
Figure S11). 
The concentration of K+ ions in tear fluid of healthy individuals is 20-42 mmol L-1.30 
However, in dry eye syndrome caused by MGD or LGD, tear K+ ion concentration increases by 
2.5% and 3.8%, respectively.40 This requires a sensor sensitivity of ~0.6 mmol L-1 and ~0.9 
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mmol L-1. The presence of both MGD and LGD increases the K+ ion concentration by 5.8%, 
requiring a sensitivity of ~1.4 mmol L-1. As the concentration of K+ ions increased from ion-free 
to 100 mmol L-1 at 25 °C, fluorescence intensity of diaza-18-crown-6 (25 µmol L-1) increased 
97.7% (Fig. 3e inset). To detect K+ ions within the physiological range of tear fluid (20-50 mmol 
L-1), the samples were diluted 16 fold. After dilution, the fluorescence intensity of the probe 
within the physiological range increased 28.8% (Fig. 3e, Fig. S10b). The sensitivity of K+ ion 
sensor was 1.2 mmol L-1 which met the requirement for the diagnosis of dry eye. 
To sense divalent metal ions, o-acetanisidide was utilized, where the N-(2-
methoxyphenyl)iminodiacetate served as a generic chelation site (Fig. 4a). Among 
mono/divalent ions (1.0-100.0 mmol L-1) in the presence of o-acetanisidide (25 µmol L-1, tris 
buffered, pH 7.4, 150 mmol L-1) at 25 °C, Ca2+ ions (100 mmol L-1) had the highest fluorescence 
intensity (1.2 fold higher than Ni2+ ions and 2 fold higher than Mg2+ ions), due to the site specific 
1:1 chelation (Fig. 4b). The dissociation constant of Ca2+ ions was calculated to be 0.9 mmol L-1 
(Eq. 2). The chelation of divalent metal ions depended on the pH; increasing the pH value from 
5.5 to 8.0 enhanced the fluorescence intensity 2.6 fold and 1.5 fold for o-acetanisidide in the 
presence of Mg2+ and Ca2+ ions, respectively, showing stability within the physiological pH 
range (~7.4) of tear fluid (Fig. 4c). As the concentration of o-acetanisidide was increased from 3 
µmol L-1 to 50 µmol L-1, the fluorescence intensities for Mg2+ and Ca2+ ions increased 9.9 and 
12.3 fold, respectively (Fig. 4d). The fluorescence intensity was affected by temperature; for 
example, when temperature increased from 25 °C to 40 °C, the fluorescence intensity of o-
acetanisidide decreased ~26% (Fig. S12a).  
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Figure 4. Quantification of divalent metal ions in buffer solution (tris, pH 7.4, 150.0 mmol L-1) 
at 25 °C. (a) Chelation mechanism of o-acetanisidide with divalent metal ions. (b) Fluorescence 
readouts of o-acetanisidide in the presence mono/divalent metal ions in aqueous solutions. (c) 
The effect of pH on fluorescence readouts of o-acetanisidide (25 µmol L-1) at constant Mg2+ and 
Ca2+ ion concentrations (100.0 mmol L-1) in aqueous solutions. (d) Fluorescence intensity 
readouts of Mg2+ and Ca2+ ions (100 mmol L-1) as the concentration of o-acetanisidide were 
varied from 3-50 µmol L-1. (e) Quantification of 16-fold diluted Ca2+ ions on G1 matrix at a 
constant o-acetanisidide concentration (25 µmol L-1) in aqueous solutions. Insets show the 
quantification of non-diluted Ca2+ ions on G1 matrix. Error bars represent the standard deviation 
(n=3). Shadows in Fig. 4c and 4e show the physiological pH and Ca2+ ion range.  
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The concentration of Ca2+ ions in tear fluid of healthy individuals is 0.4-1.1 mmol L-1.42 
However, in dry eye syndrome caused by MGD or LGD, tear Ca2+ ion concentration increases 
2.5% and 5.0%, respectively. This requires a sensor sensitivity of 0.02-0.04 mmol L-1. The 
presence of both MGD or LGD increases the Ca2+ ion concentration 7.5%, requiring a sensitivity 
of ~0.06 mmol L-1.40 As the concentration of Ca2+ ions increased from 0.25 mmol L-1 to 1.50 
mmol L-1 at 25 °C, fluorescence intensity increased two fold in the presence of o-acetanisidide 
(25 µmol L-1) (Fig. 4e inset). The high sensitivity range of the fluorescent o-acetanisidide is 
0.25-1.5 mmol L-1. To detect Ca2+ ions within the physiological concentration range of tear fluid, 
the sample does not need to be diluted. Even after 16-fold dilution, the fluorescence intensity of 
Ca2+ ion solution (0.25 mmol L-1 to 1.5 mmol L-1) increased 41% on the G1 matrix (Fig. 4e, Fig. 
S10c). The sensitivity of the Ca2+ ion sensor was calculated to be 0.03 mmol L-1 which met the 
requirements of dry eye diagnostic sensitivity. 
pH changes can be quantified using seminaphtorhodafluor (pKa value ~7.5), the fluorescence 
emission shifts from yellow-orange (λ=580 nm) to deep red (λ=640 nm) under acidic and basic 
conditions, respectively (Fig. 5a). As the concentration of seminaphtorhodafluor was increased 
from 3 µmol L-1 to 50 µmol L-1 at a constant pH value (7.4), the fluorescence intensity increased 
15 fold (Fig. 5b). The tear fluid pH of a healthy individual is ~7.4; however, in dry eye (MGD 
and LGD) the pH increases to ~7.9.41 Changes in the composition and/or concentration of mucin 
secreted by the goblet cells increase the pH of the overlying aqueous layer.41 This requires a 
sensor sensitivity of ~0.5 pH units. The seminaphtorhodafluor on G1 matrix exhibited a 
fluorescence intensity decrease of 2.9 fold as the pH increased from 7.0 to 9.0 (Fig. 5c inset). 
The sensitivity of seminaphtorhodafluor was 0.1 pH units after a 16-fold dilution, which met the 
requirement of the sensor sensitivity (Fig. 5c, Fig. S10d). Seminaphtorhodafluor also showed 
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low interference in the presence of mono/divalent ions in solution (Fig. 5d). Additionally, the 
fluorescence intensity of seminaphtorhodafluor decreased ~36% when the temperature increased 
from 25 °C to 40 °C (Fig. S12b). 
 
Figure 5. Quantification of pH values in buffer solutions (tris, 150.0 mmol L-1) at 25 °C. (a) 
Principle of operation of seminaphtorhodafluor. (b) Fluorescence intensity readouts as the 
concentration of seminaphtorhodafluor was varied from 3-50 µmol L-1 at pH=7.4 in aqueous 
solutions. (c) Quantification of tris buffer pH (inset) and 16-fold diluted tris buffer (150.0 mmol 
L-1, pH=7.4) on G1 matrix at a constant seminaphtorhodafluor concentration (25 µmol L-1). (d) 
Relative fluorescence intensity readouts of mono/divalent ions at a constant concentration of 
seminaphtorhodafluor (25 µmol L-1) at pH 7.4. Error bars represent standard deviation (n=3) in 
aqueous solutions. Shadows in Fig. 5c show the physiological pH range. 
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To investigate potential ion interference in the quantification of electrolyte concentrations, 
the 16-fold diluted solutions containing two or more ions both in solution and on the G1 matrix 
were analyzed (Fig. S13). Fluorescence intensity changes of diaza-15-crown-5 for Na+ ion (30-
180 mmol L-1) sensing in the presence of K+ (42 mmol L-1), Ca2+ (1.1 mmol L-1), and Mg2+ (0.4 
mmol L-1) ions were evaluated. The maximum deviation for the interference of K+ ions in Na+ 
ion sensing was 2.4% in solution and 4.0% on the G1 matrix. For Na+ ion sensing interfered by 
K+ and Ca2+ ions, the deviation was 5.0% in solution and 2.8% on the G1 matrix. Additionally, in 
the presence of K+, Ca2+ and Mg2+ ions, Na+ ion measurement interference was 2.7% in solution 
and 4.7% on the G1 matrix. In the physiological range of human tear fluid (120-180 mmol L-1), 
the deviations of Na+ ion measurements were less than 1.4%. The deviations for Na+ ion sensing 
from the results from fluorescent crown ether derivatives were within the accuracy limit of target 
selectivities. Moreover, ion sensing in artificial tear fluid was evaluated and compared with 
electrolyte solutions in buffers (Fig. S14). Artificial tear fluid was prepared to mimic tear fluid 
composition. The maximum deviations for Na+ ions (0-200 mmol L-1), K+ ions (0-50 mmol L-1), 
Ca2+ ions (0-2 mmol L-1), pH (7.0-9.0) sensing on the G1 matrix were 5%, 7%, 9% and 4%, 
respectively, which were within the accuracy of target electrolyte sensing. Therefore, these 
fluorescent sensors can be used for ion sensing in artificial tear fluid on the G1 matrix. 
To demonstrate the utility of the paper-based microfluidics for tear analysis, a microfluidic 
system including a sample collection device and a portable readout device was developed. 2 μL 
of each fluorescent sensor (Na+, K+, Ca2+ ions and pH sensors) was dispensed onto the tip of 
each branch of the microfluidic device (Fig. 6a and Movie S1). The sample collection device was 
designed to be amenable to potential clinical use consisting of a dilution chamber (~75 μL DI 
water) connected to a capillary tube, which can sample tears (~5 μL) (Fig. S15). The diluted 
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sample was mixed thoroughly and flowed to the opposite side of the chamber, which was 
connected to the paper-based microfluidic device (Fig. 6b and Movie S2).  A portable readout 
device was developed for blocking the ambient light and exciting the fluorescent probes 
impregnated into the branches of the paper-based microfluidic device (Fig. 6c). Four LEDs with 
different emission wavelengths (λem: 366, 460, 505, and 515 nm) illuminated the sensing regions 
from the rear. The four-channel paper-based microfluidic device was placed in a groove covered 
with a longpass filter, which was located in the interlayer of the readout device. Figure S16 
shows light attenuation of each LED light using the longpass filters (420, 495, 515, and 590 nm). 
The fluorescence images of probes at different artificial tear fluid compositions on paper-based 
microfluidic device were captured by an iPhone 6S camera positioned over a wide-angle lens in 
the readout device using a smartphone app. (Shoot) (Fig. 6d-f, S17). Movie S3 shows the 
operation of the readout device for sample measurements. 
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Figure 6. Microfluidic system for tear fluid analysis. (a) Paper-based microfluidic device 
impregnated with fluorescent probes. Scale bar: 2 mm. (b) Sample collection and dilution device 
using a capillary tube. Scale bar: 1 cm. (c) The schematic of the portable readout device. (d) The 
use of the portable readout device for capturing the image of the fluorescent probes. (e) 
Photograph of the interlayer groove to place the paper-based microfluidic device. Scale bar: 1 cm. 
(f) Screenshot of the smartphone app. capturing an assay image. Red square (1×1 mm2) in the 
magnified screenshot (blue dash circle) shows the selected sensing region. 
 
The quantification of electrolyte concentrations in the artificial tear fluid was carried out by a 
portable readout device and quantitatively analyzed using a smartphone app. and software. A 
square (1×1 mm2) in the central of the captured fluorescence image was selected from the 
sensing regions (2×2 mm2) at the end of each branch of the paper device for signal processing. 
𝐼′(𝐶) = 𝐼(𝐶)/𝐼0(𝐶) is the concentration dependent fluorescence intensity ratio, which can be 
expressed as: 
𝐼′(𝐶) = I′𝑠(1 − e
−∝𝐶)                                                                                                          (Eq. 3) 
where I′𝑠 represents the saturated fluorescent intensity ratio, α is the saturation decay constant, 
and C is the electrolyte concentration. Eq. 3 was used to express fluorescent intensity as a 
function of electrolyte concentration. In this case, we investigated the sensitivity of electrolyte 
sensing by measuring fluorescent intensity (Fig. 7 and S18). The calibration data was compiled 
by subtracting the background (paper without fluorescent probe) (Eq. S1). Increase in Na+ ion 
concentration from 100 mmol L-1 to 200 mmol L-1 in artificial tear fluid within the physiological 
range increased the fluorescence intensity of diaza-15-crown-5 by 18% on the paper-based 
microfluidic device (Fig. 7a). The sensitivity of diaza-15-crown-5 sensor on the microfluidic 
 24 
device was 3.0 mmol L-1, which met the requirement for Na+ ion sensing in dry eye diagnosis 
(~3.0 mmol L-1). Figure S19 shows the reproducibility of the sample measurement process using 
the sample collection device (Fig. 6b) that performed 2 to 64 fold dilutions. The average 
measurement error due to sample dilution was 1.3 mmol L-1 Na+ ions (Fig. S19a). As the 
concentration of K+ ions was increased within the physiological range in artificial tear fluid (20 
mmol L-1 to 50 mmol L-1), the fluorescence intensity of diaza-18-crown-6 sensor on the 
microfluidic device increased by 26% (Fig. 7b). The sensitivity of diaza-18-crown-6 sensor was 
1.3 mmol L-1, which met the requirement for K+ sensing in dry eye diagnosis (~1.4 mmol L-1). 
The average measurement error due to sample dilution was 0.8 mmol L-1 K+ ions (Fig. S19b). 
Additionally, as the concentration of Ca2+ ions concentration in artificial tear fluid was increased 
from 0.5 mmol L-1 to 2.0 mmol L-1, the fluorescence intensity of o-acetanisidide sensor on the 
microfluidic device increased 47% (Fig. 7c). The sensitivity of o-acetanisidide was 0.03 mmol L-
1, which met the requirement for Ca2+ sensing (0.02-0.04 mmol L-1) in dry eye diagnosis. The 
average measurement error due to sample dilution was 0.02 mmol L-1 Ca2+ ions (Fig. S19c). An 
increase in pH value from 7.0 to 8.0 in artificial tear fluid decreased the fluorescence intensity of 
seminaphtorhodafluor by 13% on the microfluidic device. The average measurement error due to 
sample dilution was 0.1 pH values (Fig. S19d). The sensitivity was calculated to be 0.1 pH units, 
which met the requirement for pH sensing in dry eye diagnosis (~0.5 pH unit) (Fig. 7d). The 
fluorescence intensity measurements of paper-based microfluidic device using the readout 
system integrated with the smartphone app. and ImageJ were consistent with the results from the 
microplate reader. Therefore, the smartphone app. integrated with ImageJ can be utilized for dry 
eye diagnosis. The paper-based microfluidic devices remained exposed to air during 
measurements. We performed experiments to measure the effect of evaporation on the 
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fluorescence intensity readouts in paper strips with different lengths (4, 8, 16, and 32 mm) during 
the wicking process. The evaporation from the electrolyte solutions during wicking process on 
paper device did not have significant effect on the fluorescence readouts (Fig. S20). The average 
standard error due to evaporation among different strips was 0.14, 0.12, 0.04 mmol L-1, and 0.13 
pH units for Na+, K+, Ca2+, and pH measurements, respectively. Additionally, batch-to-batch 
measurements of electrolytes in the paper-based microsystem showed that the average detection 
errors were 3.0 mmol L-1 (Na+ ions), 1.4 mmol L-1 (K+ ions), 0.02 mmol L-1 (Ca2+ ions), and 0.13 
pH values, indicating high reproducibility in independent trials (Fig. S21).  
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Figure 7. Quantifications of electrolytes in artificial tear fluid using the smartphone readout 
system: (a) Na+ ions, (b) K+ ions, (c) Ca2+ ions and (d) H+ ions sensing readout by ImageJ. Scale 
bars: 2 mm. Insets in (a) and (b) show Na+ ion concentration in the range of 130-150 mmol L-1 
and K+ ion concentration in the range of 24-26 mmol L-1. Error bars represent standard deviation 
(n=3). Curves (red dashes) were fitted using Eq. 3. Shadows show the physiological Na+, K+, 
Ca2+ ion and pH range.  
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Sub-types of dry eye (MGD and LGD) were simulated in artificial tear fluid by varying the 
concentrations of Na+, K+, and Ca2+ ions (Table 1). Figure 8a-c shows the variation of inferred 
ion concentration in artificial tear samples. Figure S22 shows the measurements of pH values. 
Ion concentrations in artificial tear sample 1-3 (simulated dry eye samples) were higher than that 
in control (simulated healthy sample). The maximum deviation of Na+ ion sensor was calculated 
to be 1% according to the standard curve, which was within the accuracy for dry eye diagnosis 
(~2%). Moreover, the maximum deviation of the fluorescent sensors for K+, Ca2+ ions and pH 
were 2%, 3%, and 2%, respectively, which were within the accuracy for dye eye diagnosis (~7%). 
Additionally, total electrolyte concentration of human tear fluid is correlated with tear osmolarity, 
which increases with dry eye severity.42 Different severity stages of dry eye were simulated by 
varying the concentrations of Na+, K+, and Ca2+ ions (Table 1) on the paper-based microfluidic 
device. The ion concentrations and pH value were measured in the portable readout device. The 
images were captured using a smartphone app. and analyzed by ImageJ. The maximum deviation 
of the sensor in all samples was 1.4%, which was within the accuracy for dry eye diagnosis (~2%) 
(Fig. 8d). 
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Table 1. Ion concentrations in artificial tear samples from sub-types and different severity stages  
Subtype-
Differentiation 
Ions 
Control 
(mmol L-1) 
Sample 1 
(MGD) 
(mmol L-1) 
Sample 2 
(LGD) 
(mmol L-1) 
Sample 3 
(MGD+LGD) 
(mmol L-1) 
Na+ 133.2 136.1 142.2 145.1 
K+ 24.0 24.6 24.9 25.4 
Ca2+ 0.80 0.82 0.84 0.86 
Severity 
Stages 
Ions 
Normal 
(mmol L-1) 
Mild stage 
(mmol L-1) 
Moderate 
stage 
(mmol L-1) 
Severe stage 
(mmol L-1) 
Na+ 135 145 155 165 
K+ 24 25 26 27 
Ca2+ 0.80 0.85 0.90 0.95 
 
 
Figure 8. Quantitative analysis of simulated artificial tear samples. (a) Sub-type differentiation 
of dry eye: inferred (a) Na+, (b) K+, (c) Ca2+ ion concentrations and (d) different stages of dry eye. 
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Error bars represent the standard deviation (n=3). *: p < 0.05, **: p < 0.01, ***: p < 0.001, 
compared with control. 
 
CONCLUSIONS 
We have developed paper-based microfluidics, device designs and system integration strategies 
for a new class of dry eye diagnostics based on fluorescent chelating agents. The microfluidic 
system containing a capillary sample collection tube and portable readout device shows high 
selectivity and sensitivity in detecting tear electrolytes. The paper-based microfluidic sensor and 
mechanical readout device allow for quantification of the fluorescence signal to report on the 
concentration of electrolytes using a smartphone for application in the diagnosis of dry eye at 
point-of-care settings. Sensing electrolytes in simulated human tear fluid using our microfluidic 
system provides diagnostics information on the sub-types of dry eye and their severity within 3 
minutes. The miniaturized microfluidics and portable readout device highlight the practical 
applicability and effectiveness of the microfluidic system for dry eye diagnostics. This 
microfluidic system may provide new opportunities for the diagnosis and differentiation of 
ocular disease, such as MGD and LGD. The future directions of our present work in translation 
to clinical settings include testing with patient samples and improving sensor accuracy and 
reliability.  
 
ASSOCIATED CONTENT 
Supporting Information 
 30 
Microscopic images of G1 paper and G41 paper under brightfield; Optimization of CO2 laser 
radiation fluence and beam speed for ablating filter paper-G1; Photographs of DI water diffusion 
on microfluidic channels with different length, different width, different viscosity of fluid and 
different number of channels; Fluorescence intensity readouts of Na+ and K+ ions with varied 
concentrations of fluorescent probe; Effect of variations in temperature on fluorescence intensity; 
Photographs of DMSO on G1 paper dried in the air; Calibration curves of electrolyte sensing on 
G1 paper using microplate reader measurement; Calculation of sensitivity of the fluorescent 
sensors based on International Union of Pure and Applied Chemistry (IUPAC) guidelines; 
Quantification of ion interference in buffer solution and artificial tear fluid; Light attenuation of 
LED lights using different optical filters; The design of the sample collection device and its 
potential clinical use; Calibration curves of electrolyte sensors using the paper-based 
microfluidic system; Quantifications of evaporation effect on sampling process; Design of the 
sample collection device and its potential clinical use; Batch-to-batch experiment; Equation for 
background subtraction; Movies of sample collection and measurements. 
 
Acknowledgement 
The authors thank J.L. Martinez-Hurtado and Ning Hu for discussions on data processing, the 
readout device, and Jessica Campos and Macro Rocca for their help with schematics. 
 
AUTHOR INFORMATION 
Corresponding Author 
* ayetisen@mgh.harvard.edu, syun@mgh.harvard.edu 
 31 
Author Contributions 
A.K.Y. conceived the idea. N.J., A.K.Y., and A.G. performed the experiments. S.M.P. 
contributed to schematics. A.K.Y. and N. J. wrote the manuscript. S.H.Y., A.K., G.U.R.E., H.B., 
Y.Z.S., J.S.W. and A.T. made intellectual contributions and revised the manuscript. †These 
authors contributed equally. 
Notes 
We declare no competing financial interests. 
REFERENCES 
1. D. Pankratov, E. González‐Arribas, Z. Blum and S. Shleev, Electroanalysis, 2016, 28, 
1250-1266. 
2. M. Guzmán, I. Keitelman, F. Sabbione, A. S. Trevani, M. Giordano and J. Galletti, Clin. 
Exp. Immunol., 2016, 184, 248-256. 
3. J. R. Cameron and A. J. Tatham, Acta Ophthalmol., 2016, 94, 533-539. 
4. J. P. Craig and A. Tomilnson, Optom. Vis. Sci., 1997, 74, 8-13. 
5. F. Holly, Trans Ophthalmol Soc U K, 1984, 104, 374-380. 
6. M. Rolando and M. Zierhut, Surv Ophthalmol., 2001, 45, S203-S210. 
7. L. Zhou and R. W. Beuerman, Prog Retin Eye Res, 2012, 31, 527-550. 
8. P. E. King-Smith, B. A. Fink, N. Fogt, K. K. Nichols, R. M. Hill and G. S. Wilson, 
Invest. Ophthalmol. Vis. Sci., 2000, 41, 3348-3359. 
9. E. Goto, Y. Monden, Y. Takano, A. Mori, S. Shimmura, J. Shimazaki and K. Tsubota, 
Br. J. Ophthalmol., 2002, 86, 1403-1407. 
10. D. A. Sullivan, D. A. Dartt and M. A. Meneray, Lacrimal gland, tear film, and dry eye 
syndromes 2: basic science and clinical relevance, Springer Science & Business Media, 
New York, 2012. 
11. D. R. Korb and J. V. Greiner, in Lacrimal gland, tear film, and dry eye syndromes, 
Springer, New York, 1994, pp. 293-298. 
12. L. T. Jones, Am. J. Ophthalmol., 1966, 62, 47-60. 
13. E. Goto, Y. Yagi, Y. Matsumoto and K. Tsubota, Am. J. Ophthalmol., 2002, 133, 181-
186. 
14. C. S. De Paiva, Z. Chen, D. D. Koch, M. B. Hamill, F. K. Manuel, S. S. Hassan, K. R. 
Wilhelmus and S. C. Pflugfelder, Am. J. Ophthalmol., 2006, 141, 438-445. 
15. E. D. Donnenfeld, K. Solomon, H. D. Perry, S. J. Doshi, M. Ehrenhaus, R. Solomon and 
S. Biser, Ophthalmology, 2003, 110, 1023-1029. 
16. R. T. Ang, D. A. Dartt and K. Tsubota, Curr Opin Ophthalmol, 2001, 12, 318-322. 
17. J. J. Nichols and L. T. Sinnott, Invest. Ophthalmol. Vis. Sci., 2006, 47, 1319. 
 32 
18. C. G. Begley, B. Caffery, K. K. Nichols and R. Chalmers, Optom. Vis. Sci., 2000, 77, 40-
46. 
19. O. Schirmer, Graefes Arch Clin Exp Ophthalmol, 1903, 56, 197-291. 
20. T. Hamano, Folia Ophthalmol Jpn, 1991, 42, 719-727. 
21. U. Benelli, M. Nardi, C. Posarelli and T. G. Albert, Cont Lens Anterior Eye, 2010, 33, 
61-67. 
22. V. Y. Bunya, N. M. Fuerst, M. Pistilli, B. E. McCabe, R. Salvo, I. Macchi, G.-S. Ying 
and M. Massaro-Giordano, JAMA Ophthalmol, 2015, 133, 662-667. 
23. R. Sambursky, W. F. Davitt III, M. Friedberg and S. Tauber, Cornea, 2014, 33, 812-818. 
24. H. E. Kaufman, Cornea, 2013, 32, 211-216. 
25. S. Chotikavanich, C. S. de Paiva, J. J. Chen, F. Bian, W. J. Farley and S. C. Pflugfelder, 
Invest. Ophthalmol. Vis. Sci., 2009, 50, 3203-3209. 
26. M. B. Goren and S. B. Goren, Am. J. Ophthalmol., 1988, 106, 570-574. 
27. C. Baudouin, T. Bourcier, F. Brignole, F. Bertel, M. Moldovan, M. Goldschild and A. 
Goguel, Graefes Arch Clin Exp Ophthalmol, 2000, 238, 900-904. 
28. K. Karns and A. E. Herr, Anal. Chem., 2011, 83, 8115-8122. 
29. K. Yamada, S. Takaki, N. Komuro, K. Suzuki and D. Citterio, Analyst, 2014, 139, 1637-
1643. 
30. N. M. Farandos, A. K. Yetisen, M. J. Monteiro, C. R. Lowe and S. H. Yun, Adv. 
Healthcare Mater., 2015, 4, 792-810. 
31. J. P. Gilbard, Int. Ophthal. Clin., 1994, 34, 27-36. 
32. V. L. Alexeev, S. Das, D. N. Finegold and S. A. Asher, Clinical Chemistry, 2004, 50, 
2353-2360. 
33. A. K. Yetisen, J. Martinez-Hurtado, A. Garcia-Melendrez, F. da Cruz Vasconcellos and 
C. R. Lowe, Sens. Actuator B-Chem., 2014, 196, 156-160. 
34. A. K. Yetisen, M. S. Akram and C. R. Lowe, Lab Chip, 2013, 13, 2210-2251. 
35. J. M. Tiffany, Eye, 2003, 17, 923-926. 
36. R. D. Hancock and A. E. Martell, Chem. Rev., 1989, 89, 1875-1914. 
37. G. W. Gokel, Crown Ethers and Cryptands, Royal Society of Chemistry, Cambridge, 
UK, 1994. 
38. M. A. Kuhn and R. P. Haugland, US Patent, 5405975, 1995. 
39. V. V. Martin, K. R. Gee, R. P. Haugland and Z. Diwu, US Patents,  6962992 , 2005. 
40. J. P. Gilbard, Int Ophthalmol Clin, 1994, 34, 27-36. 
41. W. H. Coles and P. A. Jaros, Br. J. Ophthalmol., 1984, 68, 549-552. 
42. P. Versura, V. Profazio and E. Campos, Curr. Eye Res., 2010, 35, 553-564. 
 
